Pfizer: New favorable data on the bivalent vaccine

Pfizer: new favorable data on the bivalent vaccine

Pfizer: FDA clears bivalent booster vaccine

Moderna: Spikevax Bivalent authorized in Switzerland

Moderna: green light for Spikevax Bivalent in the UK